Covestor’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
SL
Covestor's CGEM Position: Q3 2026 in Review
Covestor reduced its Cullinan Oncology (CGEM) stake by 58% in Q3 2026, selling an estimated $364 and leaving 14 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2417.
Covestor first reported a position in CGEM in Q3 2023 and has held it in 11 quarters since. The position peaked at $1K in Q2 2026. 125 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Covestor held 14 shares of Cullinan Oncology worth $0 as of Q3 2026.
- Covestor sold 19 Cullinan Oncology shares in Q3 2026, an estimated $364.
- Cullinan Oncology made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2417 holding.
- Covestor first reported a position in Cullinan Oncology in Q3 2023 and has held it in 11 quarters since.
- Covestor's Cullinan Oncology position peaked at $1K in Q2 2026.
- 125 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.